참고문헌
- Albarello L, Pecciarini L, Doglioni C (2011). HER2 testing in gastric cancer. Adv Anat Pathol, 18, 53-9. https://doi.org/10.1097/PAP.0b013e3182026d72
- Allgayer H, Babic R, Gruetzner KU, et al (2000). c-erbB-2 is of inde-pendent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. J Clin Oncol, 18, 2201-9. https://doi.org/10.1200/JCO.2000.18.11.2201
- Bang YJ, Van Cutsem E, Feyereislova A, et al; Trial Investigators. (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet, 376, 687-97 https://doi.org/10.1016/S0140-6736(10)61121-X
- Boku N (2014). HER2-positive gastric cancer. Gastric Cancer, 17, 1-12. https://doi.org/10.1007/s10120-013-0252-z
- Chong VH, Telisinghe PU, Jalihal A (2009). Helicobacter pylori infection and correlation with upper gastrointestinal pathologies: an eleven-year trend. J Gastrointest Liver Dis, 18, 514-5.
- Chong VH, Telisinghe PU, Abdullah MS, Chong CF (2014). Gastric cancer in Brunei Darussalam: epidemiological trend over a 27 year period (1986-2012). Asian Pac J Cancer Prev, 15, 7281-5. https://doi.org/10.7314/APJCP.2014.15.17.7281
- Grabsch H, Sivakumar S, Gray S, et al (2010). HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series. Cell Oncol, 32, 57-65.
- Gomez-Martin C, Lopez-Rios F, Aparicio J, et al (2014). A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond. Cancer Lett, 351, 30-40. https://doi.org/10.1016/j.canlet.2014.05.019
- International Agency for Research on Cancer (IARC). GLOBOCAN 2012. www.globocan.iarc.fr/ (accessed 6th December 2015).
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jorgensen JT (2010). Targeted HER2 treatment in advanced gastric cancer. Oncol, 78, 26-33. https://doi.org/10.1159/000288295
- Jorgensen JT, Hersom M (2012). HER2 as a prognostic marker in gastric cancer - a systematic analysis of data from the literature. J Cancer, 3, 137-44. https://doi.org/10.7150/jca.4090
- Luo HQ, Han L, Jiang Y (2014). Meta-analysis of six randomized control trials of chemotherapy plus anti-HER monoclonal antibody for advanced gastric and gastroesophageal cancer. Asian Pac J Cancer Prev, 15, 5343-8. https://doi.org/10.7314/APJCP.2014.15.13.5343
- Madani SH, Rahmati A, Sadeghi E, et al (2015). Survey of Her2-neu expression and its correlation with histology of gastric carcinoma and gastroesophageal junction adenocarcinoma. Asian Pac J Cancer Prev, 16, 7755-8. https://doi.org/10.7314/APJCP.2015.16.17.7755
- Rakhshani N, Kalantari E, Bakhti H, Sohrabi MR, Mehrazma M (2014). Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray. Asian Pac J Cancer Prev, 15, 7597-602. https://doi.org/10.7314/APJCP.2014.15.18.7597
- Ruschoff J, Hanna W, Bilous M, et al (2012). HER2 testing in gastric cancer: a practical approach. Mod Pathol, 25, 637-50. https://doi.org/10.1038/modpathol.2011.198
- Selcukbiricik F, Erdamar S, Buyukunal E, Serrdengecti S, Demirelli F (2014). Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy? Asian Pac J Cancer Prev, 15, 10607-11.
- Sugano K (2015). Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol, 29, 895-905. https://doi.org/10.1016/j.bpg.2015.09.013
- Torres J, Lopez L, Lazcano E, Camorlinga M, Flores L, Munoz O (2005). Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev, 14, 1874-7. https://doi.org/10.1158/1055-9965.EPI-05-0113
- Wada R, Hirabayashi K, Ohike N, Morii E (2016). New guidelines for HER2 pathological diagnostics in gastric cancer. Pathol Int, 66, 57-62. https://doi.org/10.1111/pin.12390
- Watanabe M, Ito H, Hosono S, et al (2015). Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci, 106, 1738-43. https://doi.org/10.1111/cas.12821
- Yen RL, Telisinghe PU, Cunningham A, Abdullah MS, Chong CF, Chong VH (2014). Profiles of Epstein-Barr virus associated gastric carcinomas in Brunei Darussalam. Asian Pac J Cancer Prev, 15, 10489-93.